Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Paoletti

Showing results (61-70 of 210) with videos related to

Pageof 21
Sort By:
Methods in Enzymology|January 1, 1987
Vaccinia virus as an expression vectorA Piccini, M E Perkus, E Paoletti
The Journal of Biological Chemistry|December 25, 1975
Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virionsS A Martin, E Paoletti, B Moss
Journal of Leukocyte Biology|July 1, 1995
Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseasesM E Perkus, J Tartaglia, E Paoletti
Virus Research|December 1, 1990
Extrachromosomal recombination in vaccinia-infected cells requires a functional DNA polymerase participating at a level other than DNA replicationR J Colinas, R C Condit, E Paoletti
Thescientificworldjournal|April 24, 2007
Chronic vs. short-term acute O3 exposure effects on nocturnal transpiration in two Californian oaksN E Grulke, E Paoletti, Robert L Heath
Virology|October 1, 1993
An update on the vaccinia virus genomeG P Johnson, S J Goebel, E Paoletti
Environmental Pollution (Barking, Essex : 1987)|June 17, 2006
Comparison of calculated and measured foliar O3 flux in crop and forest speciesN E Grulke, E Paoletti, R L Heath
Vaccine|January 1, 1992
Protection from herpes simplex virus type 2 is associated with T cells involved in delayed type hypersensitivity that recognize glycosylation-related epitopes on glycoprotein DM Wachsman, J H Luo, L Aurelian, et al.
The Journal of General Virology|December 1, 1990
Equine herpesvirus type 1 unique short fragment encodes glycoproteins with homology to herpes simplex virus type 1 gD, gI and gEJ C Audonnet, J Winslow, G Allen, et al.
Developments in Biological Standardization|January 1, 1994
Safety and immunogenicity of recombinants based on the genetically-engineered vaccinia strain, NYVACJ Tartaglia, W I Cox, S Pincus, et al.
Pageof 21

Showing results (61-70 of 210) with videos related to

Sort By:
Pageof 21
Methods in Enzymology|January 1, 1987
Vaccinia virus as an expression vectorA Piccini, M E Perkus, E Paoletti
The Journal of Biological Chemistry|December 25, 1975
Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virionsS A Martin, E Paoletti, B Moss
Journal of Leukocyte Biology|July 1, 1995
Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseasesM E Perkus, J Tartaglia, E Paoletti
Virus Research|December 1, 1990
Extrachromosomal recombination in vaccinia-infected cells requires a functional DNA polymerase participating at a level other than DNA replicationR J Colinas, R C Condit, E Paoletti
Thescientificworldjournal|April 24, 2007
Chronic vs. short-term acute O3 exposure effects on nocturnal transpiration in two Californian oaksN E Grulke, E Paoletti, Robert L Heath
Virology|October 1, 1993
An update on the vaccinia virus genomeG P Johnson, S J Goebel, E Paoletti
Environmental Pollution (Barking, Essex : 1987)|June 17, 2006
Comparison of calculated and measured foliar O3 flux in crop and forest speciesN E Grulke, E Paoletti, R L Heath
Vaccine|January 1, 1992
Protection from herpes simplex virus type 2 is associated with T cells involved in delayed type hypersensitivity that recognize glycosylation-related epitopes on glycoprotein DM Wachsman, J H Luo, L Aurelian, et al.
The Journal of General Virology|December 1, 1990
Equine herpesvirus type 1 unique short fragment encodes glycoproteins with homology to herpes simplex virus type 1 gD, gI and gEJ C Audonnet, J Winslow, G Allen, et al.
Developments in Biological Standardization|January 1, 1994
Safety and immunogenicity of recombinants based on the genetically-engineered vaccinia strain, NYVACJ Tartaglia, W I Cox, S Pincus, et al.
Pageof 21